AAAAI & ACAAI GUIDELINES Bundle (free trial)

Urticaria

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/786168

Contents of this Issue

Navigation

Page 5 of 23

6 Î The co-occurrence of CU with a number of conditions, including H. pylori infection and celiac disease, has been reported. However, evidence does not support testing for these conditions in a patient with CU with an otherwise unremarkable history and physical examination. Moreover, there are no convincing data demonstrating that treatment based on abnormal test results consistent with these conditions being present leads to improvement or change in the course of CU. (C) Î Malignancies, such as lymphoproliferative diseases and Schnitzler syndrome, can present with CU. (C) Î Approximately 30%–50% of patients with CU produce specific IgG antibodies against the FcεR1α subunit component of the high- affinity IgE receptor. (C) Î The utility of the autologous serum skin test (ASST) and autologous plasma skin test (APST) is unclear because evidence has not clearly demonstrated that this testing identifies a distinct subgroup of patients with CU. Current evidence does not support routine performance of ASSTs or APSTs in patients with CU. (C) Î The pathogenesis of autoantibody-associated urticaria remains elusive, but in vitro/ex vivo studies demonstrate a role for T cells, sCD154 (sCD40 ligand), and basophil histamine responsiveness. (LB) Î For patients with CU who present with an otherwise unremarkable history and physical examination findings, skin or in vitro testing for IgE to inhalants or foods and/or extensive laboratory testing are NOT recommended because such testing is not cost-effective and does not lead to improved patient care outcomes. (C) • Targeted laboratory testing based on history or physical examination findings is appropriate, and limited laboratory testing can be obtained. (E) Î The initial patient evaluation should be focused to determine (through history and physical examination) whether the lesions that patients describe are consistent with CU. (D) Î The medical work-up of a patient with CU should be done, keeping in mind that CU is of undetermined cause in the majority of cases. (C) Acute, Chronic and Physical Urticaria and Angioedema

Articles in this issue

Archives of this issue

view archives of AAAAI & ACAAI GUIDELINES Bundle (free trial) - Urticaria